Stomach pain and vomiting are leading to increased emergency room visits by cannabis users in the Philadelphia area.
In the aftermath of the Christmas holiday, a 37-year-old South Jersey resident, Taylor Armendariz, experienced alarming health challenges which prompted her to seek urgent medical attention. Describing herself as a regular cannabis user, Armendariz reported severe stomach pain and nausea shortly after indulging in a festive meal, including beef Wellington and apple pie, accompanied by her customary cannabis consumption. Despite her knowledge of cannabis and its effects, she found herself grappling with an acute sickness that led her boyfriend to take her to an urgent care facility.
Upon evaluation, medical professionals suggested the possibility of appendicitis and referred her to Virtua Voorhees Hospital, where a series of tests including an EKG and CT scan returned negative results. However, her symptoms persisted with extreme nausea, prompting her to experiment with techniques such as taking a hot shower, which temporarily alleviated her discomfort. It was during her second visit to the emergency room that doctors recognized the symptoms consistent with cannabinoid hyperemesis syndrome (CHS), a condition reported increasingly among long-term cannabis users.
Local emergency departments in the Philadelphia area are witnessing a surge in such cases, attributed to the greater accessibility and heightened potency of legal cannabis products following recent legislative changes. For instance, hospitals affiliated with Jefferson Health recorded at least 300 cases of CHS in the fiscal year ending July 2025—an approximate threefold increase from two years prior. This worrying trend has led medical professionals to inquire about cannabis use in patients presenting with similar symptoms.
In light of these developments, the understanding of CHS has progressed significantly. The condition, previously unrecognized, has garnered attention following the acknowledgment from federal health authorities that it constitutes a medical condition warranting formal diagnosis. Despite increasing awareness, many patients are in disbelief when diagnosed with CHS, often citing their long history of cannabis use without issue. However, experts highlight that chronic, heavy use, particularly with higher THC levels prevalent in modern products, can precipitate severe symptoms, making the syndrome more common among today’s cannabis users.
Healthcare professionals are now urging caution, as studies indicate that up to 30% of chronic cannabis users may develop CHS, which often necessitates emergency interventions to address dehydration and electrolyte imbalances resulting from severe vomiting. In Armendariz’s case, despite her initial resistance to the diagnosis, she was ultimately treated with specific medications designed to alleviate her symptoms, along with lifestyle adjustments aimed at mitigating her cannabis intake.
This uptick in CHS cases raises critical questions about the long-term effects of higher-potency cannabis products available in markets across 24 states, including New Jersey and Delaware, where recreational use has been legalized. As a result, medical professionals continue to monitor the evolving landscape of cannabis use, emphasizing the need for awareness and education surrounding its potentially serious side effects. Ultimately, for individuals like Armendariz, the road to recovery involves not just symptom management but addressing their relationship with cannabis to prevent further health complications.
Healthcare experts emphasize that as cannabis becomes increasingly accessible, understanding its implications on health remains imperative. As they research the intricacies of conditions like CHS, the focus shifts toward educating users about the risks associated with heavy and prolonged cannabis consumption.
